A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly

Wing, Lindon M.H., Reid, Christopher M., Ryan, Philip, Beilin, Lawrence J., Brown, Mark A., Jennings, Garry L.R., Johnston, Colin I., McNeil, John J. +4 more·2003·New England Journal of Medicine

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Resolving the differences between ACE inhibitors and diuretics - ALLHAT and ANBP2
    Fiona Turnbull, Bruce Charles Neal · 2004 · Australian Prescriber
  2. Aldosterone and the cardiovascular complications of chronic kidney disease
    Joanna R. Powell · 2011 · Enlighten: Theses (The University of Glasgow)
  3. Hypertension: A Clinical Pharmacist's Synopsis of JNC 7
    Jocelyn D. Jones, Keecia D. King, Frank S. Emanuel · 2004 · American Journal of Pharmaceutical Education
  4. Lifestyle Factors and Risk of Heart Failure: A Prospective Cohort Study
    Yujie Wang · 2013
  5. Gerontologic nurse practitioner care guidelines
    Donna Flannery, Cynthia J. Gerstenlauer · 2003 · Geriatric Nursing
  6. Resilience, Motivational Factors, and Medication Adherence Among Rural Older Adults
    Jamie M. Besel · 2021 · UA Campus Repository (The University of Arizona)
  7. Réplica
    J.C. Martí Canales · 2005 · Medicina de Familia SEMERGEN
  8. Hypertonie
    Heinz J. Kilbinger, K. H. Rahn · 2006 · Springer eBooks
  9. Miscellany
    William Clifford Roberts · 2003 · The American Journal of Cardiology
  10. Inhibitors of the RAS: Evidence-Based Medicine
    Werner Schulz · 2004 · Handbook of experimental pharmacology
  11. Sex Differences in Cardiovascular Drug Response
    Eline M. Rodenburg · 2012 · RePub (Erasmus University Rotterdam)
  12. GENETIC PREDICTORS OF METABOLIC SIDE EFFECTS OF DIURETIC THERAPY
    Del Aguila, Luzia Ilza Ferreira Jorge · 2014
  13. Head-to-Head Intervention Trials in Hypertension
    Massimo Volpe · 2005 · High Blood Pressure & Cardiovascular Prevention
  14. Diuretics and β-Adrenergic Blockers in the Management of Hypertension in the Elderly
    William C. Cushman · 2007 · Humana Press eBooks
  15. Treatment of Hypertension
    Massimo Volpe · 2003 · High Blood Pressure & Cardiovascular Prevention
  16. Recent Trials in Hypertension
    Samra Abouchacra, Hormazdiar Dastoor · 2012 · InTech eBooks
  17. Sodium intake and therapy resistance to ACE inhibition : renal and vascular mechanisms
    Menno J.A. Kocks · 2005 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  18. Chlorthalidone vs Other Low-Dose Diuretics—Reply
    2004 · JAMA
  19. The effects of plant-derived oleanolic acid on kidney function in male Sprague-Dawley rats and, in cell lines of the kidney and liver.
    Hlengiwe P. Madlala · 2012 · ResearchSpace (University of KwaZulu-Natal)
  20. The Importance of Dietary Measures in the Prevention and Treatment of Hypertension
    Duško Kuzmanić, Mario Laganović, Tajana Željković-Vrkić, Jelena Kos, Margareta Fištrek · 2007 · University of Zagreb University Computing Centre (SRCE)
  21. Estudo da utilização dos inibidores da enzima conversora da angiotensina, captopril e enalapril, dispensados pelas farmácias das unidades públicas de saúde do Distrito Oeste de Ribeirão Preto-SP
    Carolina Maria Xaubet Olivera · 2009 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  22. Arterielle Hypertonie bei Frauen
    Anna Mitchell, T Philipp · 2007 · Der Gynäkologe
  23. Der Stellenwert des implantierbaren Loop-Rekorders in der Synkopendiagnostik
    Schernthaner Ch, Maximilian Pichler, Bernhard Strohmer · 2005 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  24. Innovaciones en el tratamiento antihipertensivo en el adulto mayor
    Homero Gac E · 2009 · Medwave
  25. Chapter 2 Primary Prevention of Stroke by Modification of Selected Risk Factors
    M. Sloan · 2004 · Blue books of practical neurology
  26. Methodology of intervention trials in individuals
    Lawrence M. Friedman, ELEANOR B. SCHRON · 2015
  27. 研究会 第36回河口湖心臓討論会 メインテーマ : 「レニン-アンジオテンシン系と心血管系」 高血圧における血管リモデリングとレニンーアンジオテンシン系阻害作用
    Ernesto L. Schiffrin · 2004 · 心臓
  28. Principles of Primary and Secondary Prevention of Cardiovascular Disease
    Danny J. Eapen, Nima Ghasemzadeh, Naveen Bellam, Neal Kumar Bhatia, Kiran Valiani, Jia Shen, Richard J. VanDam, Peter B. Flueckiger, Daniel L. Molloy, Jenna Kay et al. · 2015 · Springer eBooks
  29. Control de la hipertensión arterial con medicamentos: actualización 2005
    Juan Manuel Toro Escobar · 2005 · IATREIA
  30. Diuretyki w leczeniu hipotensyjnym — nowe doniesienia, stare wątpliwości. Czas na rozsądny wybór?
    Urszula Brzezinska, Andrzej Tykarski · 2005 · Via Medica Journals
  31. Guidelines for Antihypertensive Treatment: The Debate on the Choice of Antihypertensive Drugs
    Antonio Salvetti, Lorenzo Ghiadoni, G. Salvetti · 2006 · Springer eBooks
  32. Angiotensin AT1 receptor antagonists in patients at high risk for cardiovascular events: the state of the art
    Jan H. Schefe, Thomas Unger · 2007 · Hot Topics in Cardiology
  33. Cardiovascular Risk Factors and Its Management
    Q Tarikul Islam, ARM Saifuddin Ekram, ASM Shawkat Ali, M. Ayub Ali · 1970 · TAJ Journal of Teachers Association
  34. Here We Go Again
    Marvin Moser · 2003 · Journal of Clinical Hypertension
  35. Hypertension in women
    Sandra J. Taler · 2008 · Current Cardiovascular Risk Reports
  36. ACE-remmers significant beter dan diuretica bij oudere mannen met hypertensie
    P. J. M. M. Toll · 2004 · Medisch-Farmaceutische Mededelingen
  37. Vascular Protection of ACE Inhibitors—Reply
    Douglas S. Jacoby, Daniel James Rader · 2003 · Archives of Internal Medicine
  38. Can we treat patients according to the latest hypertension trials?
    Kenrick Berend · 2008 · Journal of Hypertension
  39. Hipertensión arterial. El séptimo informe del Joint National Committee
    Aram V. Chobanian, George L. Bakris, Henry R. Black, William C. Cushman, L. A. Green, Joseph L. Izzo, I. Flores, M.I. Egocheaga, R. Molina, A. Dalfó et al. · 2003 · FMC - Formación Médica Continuada en Atención Primaria
  40. Escasa caracterización clínica de los pacientes con diabetes mellitus incluidos en los principales ensayos clínicos sobre hipertensión arterial
    José Miguel González-Clemente, Olga Giménez‐Palop, Assumpta Caixàs, María José Barahona, David Subías, Carme Vilardell, Gabriel Giménez‐Pérez, Dı́dac Mauricio · 2005 · Medicina Clínica
  41. Common blood pressure treatments lower the risk of major cardiovascular events
    Flávio Danni Fuchs · 2004 · Evidence-based Healthcare
  42. Present and Prospective Clinical Therapeutic Options for the Elderly Patient with Hypertension
    Monika Lechleitner, Friedrich Hoppichler · 2010 · Clinical Medicine Insights Therapeutics
  43. The number of antihypertensive agents simply reflects the grade and the risk of atherosclerosis in patients with type 2 diabetes mellitus
    Hiroyuki Ito, Mariko Abe, Masahiro Shinozaki, Takashi Omoto, Shinya Nishio, Masahide Furusho, Shinichi Antoku, Mizuo Mifune, Michiko Togane, Tsutomu Sanaka · 2013 · Journal of Diabetes Mellitus
  44. Management of hypertension in diabetes mellitus
    Ali Saeed Alzahrani · 2007 · Expert Review of Endocrinology & Metabolism
  45. Justificación de la terapia combinada con IECA y bloqueadores de los canales de calcio en la hipertensión
    Massimo Volpe, Giuliano Tocci · 2007 · Hipertensión
  46. Minder hartfalen door gebruik van chloortalidon bij hypertensie
    Marylou Toll · 2004 · Medisch-Farmaceutische Mededelingen
  47. Antihypertensive Therapy for the Prevention of Stroke in the Aging Population
    Katie M Speidel, Daniel E. Hilleman · 2006 · Aging Health
  48. Losartan
    Jorge R. Kizer · 2003 · American Journal of Cardiovascular Drugs
  49. Should patients with benign prostatic hypertrophy stop taking doxazosin in the light of the ALLHAT study?
    Tsung O. Cheng · 2005 · International Journal of Cardiology
  50. Klinischer Einsatz von Beta‐Blockern bei kardiovaskulären Indikationen: Neue Therapiestudien
    Christoph Maack, Michael Böhm · 2004 · Pharmazie in unserer Zeit
  51. Los antagonistas de los receptores de angiotensina II tienen ventajas sobre los inhibidores de la enzima de conversión de la angiotensina
    Alejandro de la Sierra · 2004 · Hipertensión y Riesgo Vascular
  52. The JNC 7 Report: Challenges and Dilemmas in Writing Guidelines
    Michael A. Weber · 2003 · Journal of Clinical Hypertension
  53. 4B.04
    E. Chowdhury, Zanfina Ademi, John Robert Moss, L. Wing, Christopher Michael Reid · 2015 · Journal of Hypertension
  54. Tratamiento de la hipertensión arterial
    Alejandro de la Sierra · 2006 · Hipertensión y Riesgo Vascular
  55. Blood pressure control and prevention of stroke
    V. Karthikeyan, Gregory Y.H. Lip · 2006 · Expert Review of Neurotherapeutics
  56. Treating Patients for Cardiovascular Protection: Combination Therapy to Achieve Complete Renin‐Angiotensin System Blockade
    Alan H. Gradman · 2007 · Preventive Cardiology
  57. Response Letter to Dr. Timo Strandberg
    Howard Neil Hodis, Wendy Jean Mack · 2014 · Journal of the American Geriatrics Society
  58. Los diuréticos en dosis bajas son los fármacos que han demostrado ser más efectivos como primera línea de tratamiento de la hipertensión arterial
    Carlos Brotons · 2004 · FMC - Formación Médica Continuada en Atención Primaria
  59. Treatment of Hypertension in the Elderly
    Thomas G. Pickering · 2004 · Journal of Clinical Hypertension
  60. More Confusing Messages From the Hypertension Treatment Trials
    Marvin Moser · 2006 · Journal of Clinical Hypertension
  61. Mechanics or mediators: arterial damage from high blood pressure
    Graham J. Macdonald · 2006 · Journal of Hypertension
  62. Antagonistas de los receptores de la angiotensina II en el tratamiento de la hipertensión arterial, las enfermedades cardiovasculares y las renales. Realidad y futuro
    Alejandro de la Sierra · 2013 · Hipertensión y Riesgo Vascular
  63. Lebenslange Nachbehandlung und Sekundärprophylaxe nach Herzinfarkt
    Peter B. Sick, Josef Niebauer, Gerhard C Schuler · 2004 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
  64. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?
    Michael Gary Nicholls · 2004 · Journal of Human Hypertension
  65. Gerontologic nurse practitioner care guideline
    Mary F. Cassidy, Dorothy Lee, Cynthia J. Gerstenlauer · 2003 · Geriatric Nursing
  66. Protocolo terap?utico de la hipertensi?n arterial en el anciano
    F. Guillén-Llera · 2006 · Medicine - Programa de Formación Médica Continuada Acreditado
  67. Los diuréticos son los fármacos de primera elección en el tratamiento de la hipertensión arterial
    Gabriel Coll de Tuero · 2004 · Hipertensión y Riesgo Vascular
  68. Knowing When to Play the Ace: The Use and Under Use of Ace Inhibitors in Primary Practice
    Katherine M. Field, Jodie L. Pepin, Monica D. Mehta · 2004 · Journal of Pharmacy Practice
  69. Optimising treatment of hypertension to prevent cardiovascular complications in type 2 diabetes
    Caroline Daly, Henry Purcell · 2003 · The British Journal of Diabetes
  70. Pulsology Reloaded
    Vittorio Palmieri, Riccardo Pini, Maria Chiara Cavallini · 2007 · Hypertension
  71. Renin‐Angiotensin‐Aldosterone System Inhibition and Improvement in Glucose Tolerance
    Adam T. Whaley‐Connell, L. Romayne Kurukulasuriya, James R. Sowers · 2009 · Journal of Clinical Hypertension
  72. Odporúčania Európskej hypertenziologickej spoločnosti a Európskej kardiologickej spoločnosti pre rok 2003 v manažmente artériovej hypertenzie
    Alberto Zanchetti · 2004
  73. Has the investment in general practice research been worthwhile?
    Chris Del Mar, Mieke van Driel · 2010 · The Medical Journal of Australia
  74. Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
    Virendra K. Misra, Wael A. Almahmeed · 2014 · Ibnosina Journal of Medicine and Biomedical Sciences
  75. Chapter 13 Hypertension
    Sverre Erik Kjeldsen, Tonje Amb Aksnes, Robert H. Fagard, Giuseppe Mancia · 2009
  76. Invited review Morbidity and mortality trials: black and white or shades of grey?
    Gordon T. McInnes · 2009
  77. Treating Hypertension Near the Eighth Decade of Life: Benefit or Burden?
    Ashley Danielle Finch · 2008
  78. Angiotensin II Receptor Antagonist/ Calcium Channel Blocker Combinations Step Therapy Criteria
    Fda-Approved Indications · 2009
  79. Angiotensin Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs), and Combinations Step Therapy Criteria
    Blue Cross · 2009
  80. Hemmstoffe des Renin-Angiotensin-Systems
    Manfred Anlauf · 2009 · Springer eBooks
  81. Another Study of First-Line Antihypertensive Therapy
    Allan S. Brett · 2003 · Journal watch
  82. Þíasíð aftur fyrsta lyfið við háþrýstingi
    Johann Agust Sigurdsson, Sigurđur Helgason · 2003 · Hirsla (Landspítali University Hospital)
  83. ACE INHIBITORS vs. DIURETICS FOR HYPERTENSION
    Harlan M. Krumholz, Sm · 2004 · Journal watch
  84. ALLHAT: More Answers or Questions?
    Raymond Kin-Man Miu, Chu‐Pak Lau, Hung‐Fat Tse · 2003 · Journal of the Hong Kong College of Cardiology
  85. ACE Inhibitors vs. Diuretics for Hypertension: Round II
    Harlan M. Krumholz, Sm · 2003 · Journal watch
  86. Australia's role in improving global cardiovascular health
    Peter Lindsay Thompson · 2014 · The Medical Journal of Australia
  87. New Hypertension Trials: What Do the Results Mean for the Elderly?
    Brianne Fairchild, Chris M. Terpening · 2004 · The Consultant Pharmacist
  88. Long-Term Effects of Chlorthalidone Versus Hydrochlorothiazide on Electrocardiographic Left Ventricular Hypertrophy in the Multiple Risk Factor Intervention Trial
    W.J. Elliott · 2012 · Yearbook of Cardiology
  89. [Thiazides or ACE inhibitors? A drug-economic analysis].
    Ivar Aursnes, Ivar Sønbø Kristiansen · 2004 · PubMed
  90. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
    Pietro Amedeo Modesti, Simone Vanni, Gian Franco Gensini · 2003 · PubMed
  91. Diuretika in der Bluthochdruck-Therapie
    Rainer Düsing · 2012 · CME
  92. Actualité des diurétiques dans la prévention cardiovasculaire chez l’hypertendu
    Pierre‐François Plouin, Guillaume Bobrie · 2003 · La Revue de Médecine Interne
  93. Efficacy and Tolerance of Betaxolol in the Treatment of Patients with Hypertension and Coronary Heart Disease
    Praca Oryginalna, Barbara Gryglewska, Tomasz K. Grodzicki · 2003 · Jagiellonian University Repository (Jagiellonian University)
  94. Nonlinear Analyses of Data in Cardiovascular Physiology and Epidemiology
    Robert A. M. Gregson · 2015 · Springer eBooks
  95. Intervention in high risk groups: hypertension
    Peter Sever, Neil R Poulter · 2005 · Oxford University Press eBooks
  96. Clinical Applications of Renin–Angiotensin System Inhibitors
    Michel Burnier · 2012
  97. Antihypertensive Drugs and Their Cardioprotective and Renoprotective Roles in the Prevention and Management of Cardiovascular Disease
    Chad Kliger, Arthur Z. Schwartzbard, Edward Fisher, HOWARD S. WEINTRAUB · 2011 · Elsevier eBooks
  98. Optimal blockade of the renin angiotensin system in cardiorenal dysfunction
    R. M. A. van de Wal · 2006
  99. History of Hypertension
    Lawrence R. Krakoff · 2005 · CRC Press eBooks
  100. Aortic Function
    Filippos K. Triposkiadis · 2008 · CRC Press eBooks